Award
Delivery Order #SPE2DR26F99B9
Delivery Order Contract for RINVOQ Medication by AmerisourceBergen Drug Corp
Buyer
Defense Logistics Agency
Award Amount
$12,837.57
Ceiling
$12,837.57
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26F99B9
NAICS
424210
This award represents a delivery order contract under the broader indefinite delivery vehicle (IDV) contract previously granted to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The contract focuses on procuring RINVOQ ER 15 MG tablets, a pharmaceutical product critical for patient treatment regimens. It supports the agency's mission to ensure reliable access to essential medications, impacting public health and pharmaceutical supply chains positively. The work involves the delivery of a specific quantity of RINVOQ tablets within a short term, highlighting efficient fulfillment of urgent medical supply needs. This contract follows a competitive process established through the parent IDV and leverages AmerisourceBergen's expertise in pharmaceutical distribution. The period of performance is brief and targeted, commencing and concluding in early 2026, emphasizing timely delivery. This delivery order adds to the ongoing relationship between the agency and AmerisourceBergen established by the overarching IDV, enhancing the continuity and responsiveness of pharmaceutical service provision.
Description
4570810659!RINVOQ ER 15 MG TABLET UU 30S